# S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

> **NCT01854749** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 57 (actual)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** S1 combined with cisplatin

## Key facts

- **NCT ID:** NCT01854749
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854749, "S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01854749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*